money-767778_960_720

1,100% generic cancer drug price increases fly below UK radar

January 30, 2017
Manufacturing and Production, Sales and Marketing Drug pricing, European Cancer congress

If you were asked what the big topic of discussion in the pharmaceutical industry was last year, there would really …

kathleen_tregoning

Sanofi announces new VP of External Affairs

January 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi

Kathleen Tregoning has been announced as Sanofi’s vice president of External Affairs and as a new member of the Executive …

u_of_liverpool

Major pharma firms join Liverpool Uni in £14m pharmacovigilance project

January 30, 2017
Research and Development, Sales and Marketing AZ, AbbVie, Eli Lilly, GSK, University of Liverpool, pharmacovigilance

The UK’s University of Liverpool is to launch a £14 million pharmacovigilance project focused on using new modelling approaches to …

astellas_japan_headquarters

Astellas and Ironwood release positive Phase 3 results for constipation drug

January 30, 2017
Research and Development, Sales and Marketing Astellas, Ironwood, constipation

Astellas Pharma, a Tokyo-based pharmaceutical, and Ironwood Pharmaceuticals, based in Cambridge, Massachusetts, have announced positive results from a Phase 3 …

msd

MSD puts best foot forward in drug pricing debate

January 30, 2017
Medical Communications, Sales and Marketing Drug pricing, MSD, Merck

MSD, known as Merck in North America, has taken a pre-emptive step in the drug pricing debate by releasing its …

ema_building_2

Amgen drug pair become first Humira biosimilars to win EU approval

January 30, 2017
Sales and Marketing AbbVie, Amgen, Amgevita, Humira, Solymbic, rheumatoid arthritis

Good news for Amgen as its two biosimilar versions of AbbVie’s blockbuster rheumatoid arthritis (RA) drug Humira (adalimumab) have been …

novo_flag

Novo Nordisk launches £115 million investment in UK despite Brexit

January 30, 2017
Research and Development, Sales and Marketing Novo Nordisk, University of Oxford, brexit

Novo Nordisk has given the UK a boost by confirming that it plans to go ahead with a £115 million …

Juno Therapeutics bring in new executive vice president

January 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, juno therapeutics

Juno Therapeutics has hired Corsee D. Sanders as its executive vice president and head of development operations. She will step …

revlimid_celgene

Celgene’s Revlimid scores first-of-its-kind myeloma indication in EU

January 27, 2017
Sales and Marketing Celgene, Revlimid, multiple myeloma

Celgene’s Revlimid (lenalidomide) has become the first licensed monotherapy treatment for newly diagnosed multiple myeloma in patients who have undergone …

verily_company_logo

Google’s life sciences business gains $800 million funding in pivot to Asia

January 27, 2017
Medical Communications, Sales and Marketing China, Temasek, Verily, google

Verily, a life sciences company owned by Alphabet, Google’s umbrella company, has announced that it has received $800 million in …

top_ten_1

Top Ten most popular articles on Pharmafile.com this week

January 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

We’re nearing the end of the first month of the year and acqusitions have begun to introduce themselves with bang, …

mr

Innovative routes to market: Rethinking the life sciences distribution model

January 27, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Deloitte, distribution

Originally published in the latest issue of Pharmafile, Deloitte’s life sciences director Lee Feander discusses the often-undervalued importance of distribution …

celgene_1_02

Celgene to acquire Delinia in a potential $775 million deal

January 27, 2017
Medical Communications Celgene, Delinia

Celgene has shelled out $300 million upfront, with a potential further $475 million in milestone payments, for Delinia, an autoimmune …

shutterstock_110597087-web

Skin cancer-detecting AI “on par with board-certified dermatologists”

January 27, 2017
Medical Communications, Research and Development AI, Cancer, skin cancer

New research has found that artificial intelligence repurposed by researchers at Stanford University to identify skin cancer in images has …

teva

Teva agrees $225 million fee in antitrust case

January 27, 2017
Medical Communications Barr Laboratories, Teva, fine

Barr Laboratories, a subsidiary of Teva Pharmaceuticals, has settled an antitrust class action for $225 million. The case relates to …

richard_bungay

New CFO for Diurnal

January 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Richard Bungay has been named as the new chief financial officer (CFO) of Diurnal; he has succeeded former CFO Ian …

imbruvica_logo_0

NICE approves Imbruvica for second-line leukaemia treatment

January 26, 2017
Medical Communications, Sales and Marketing AbbVie, CLL, Janssen, ibrutinib, imbruvica

NICE has issued its Technology Appraisal Guidance (TAG) that has recommend Imbruvica (ibrutinib) for the treatment of chronic lymphocytic leukaemia …

leukamia

Two infants in remission from leukaemia after CAR T-Cell therapy

January 26, 2017
Research and Development

Researchers at the Great Ormond Street Hospital have published the successful treatment of two infants suffering from leukaemia by treatment …

currency-166422_960_720

India’s NPPA slashes essential drug prices by up to 50%

January 26, 2017
Sales and Marketing India, nppa, pricing

India’s governmental regulatory agency, the National Pharmaceutical Pricing Authority (NPPA), has addressed the pricing of 33 medicines including antibiotics and …

The Gateway to Local Adoption Series

Latest content